A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19)
Phase 1
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000002959
- Lead Sponsor
- 1. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. patients diagnosed as Pneumonia caused by new coronavirus infection (2019-nCoV);The classification was judged as common type;
2. aged 18-70 years old;
3. patients with clear consciousness;
4. Signing the informed consent form.
Exclusion Criteria
1. Patients with serious illnesses, such as heart, liver, kidney, endocrine diseases and hematopoietic system disease;
2. Pregnant or lactating women;
3. Patients who have mental confusion, who with a history of drug abuse or dependence, who allergic to study medication, who have participated in another clinical trial within 3 months,or who have other conditions not suitable for clinical study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time of virus turning negative;pulmonary function;Antipyretic time;
- Secondary Outcome Measures
Name Time Method St Georges respiratory questionnaire, SGRQ;6-minute walk test, 6MWT;Disappearance time of cough;Incidence of adverse events;Modified Barthel Index, MBI;